Filing Details
- Accession Number:
- 0000899243-20-015389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-05 15:18:29
- Reporting Period:
- 2020-05-29
- Accepted Time:
- 2020-06-05 15:18:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061027 | Sunesis Pharmaceuticals Inc | SNSS | Pharmaceutical Preparations (2834) | 943295878 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1811378 | Tina Gullotta | Sunesis Pharmaceuticals, Inc. 395 Oyster Point Boulevard, Ste. 400 South San Francisco CA 94080 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-29 | 6,000 | $0.33 | 20,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-05-29 | 70,000 | $0.00 | 70,000 | $0.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
70,000 | 2030-05-29 | No | 4 | A | Direct |
Footnotes
- Shares acquired under the Issuer's stock purchase plan.
- One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of May 29, 2020. Thereafter, one forty-eighth (1/48th) of shares granted shall vest monthly over the next thirty-six (36) months.